BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Teva
Mallinckrodt
Healthtrust
Citi
Boehringer Ingelheim
Fish and Richardson
US Department of Justice
AstraZeneca
McKinsey

Generated: January 24, 2018

DrugPatentWatch Database Preview

ROMARK Company Profile

« Back to Dashboard

What is the competitive landscape for ROMARK, and when can generic versions of ROMARK drugs launch?

ROMARK has two approved drugs.

There are three US patents protecting ROMARK drugs.

There are one hundred and twenty-three patent family members on ROMARK drugs in forty-two countries.

Summary for ROMARK
International Patents:123
US Patents:3
Tradenames:1
Ingredients:1
NDAs:2

Drugs and US Patents for ROMARK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ROMARK

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Subscribe ➤ Subscribe
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for ROMARK

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,387,598 Composition and galenic formulation suitable for combatting affections of the lower abdomen ➤ Subscribe
6,051,576 Means to achieve sustained release of synergistic drugs by conjugation ➤ Subscribe
5,886,013 Antiviral composition ➤ Subscribe
6,020,353 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide ➤ Subscribe
5,578,621 Benzamide derivatives ➤ Subscribe
5,856,348 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide ➤ Subscribe
5,859,038 Method for treatment of helicobacter pylori infections ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ROMARK Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Julphar
QuintilesIMS
US Department of Justice
Baxter
Fuji
Cipla
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot